Health Bulletin 2/September/2022

Published On 2022-09-02 10:58 GMT   |   Update On 2022-12-13 11:49 GMT
Advertisement

Here are the top health news for the day:

Final year MBBS student at Safdarjung Hospital hangs self in hostel room

In a shocking incident, a final-year MBBS student at the Safdarjung Hospital allegedly hanged herself in a hostel room, police said. The police post at the hospital received information about the incident at 3.30 am on Thursday, they said.

The student, a resident of Delhi, was residing at the MBBS Girls Hostel, Safdarjung Hospital. She was found in a room in the MBBS Hostel of the hospital.

Advertisement

For more details, check out the link given below:

Final year MBBS student at Safdarjung Hospital hangs self in hostel room


One year service in rural, tribal areas now mandatory for PG medicos in Andhra Pradesh

 A one-year service in rural and tribal areas is to be made compulsory for post-graduate medical students who complete their course with government support.

"The government has taken a policy decision in this regard and necessary orders will be issued soon," Andhra Pradesh Principal Secretary (Health) M T Krishna Babu said.

For more details, check out the link given below:

One year service in rural, tribal areas now mandatory for PG medicos in Andhra Pradesh


NMC reverses its stand on TEQ norms for non medical teachers, says old rules will be followed

 Filing an affidavit before the Delhi High Court, the National Medical Commission (NMC) has reversed its stand on the reduction of permissible percentage of "non-medical" teachers with medical M.Sc/Ph.D qualifications.

The Apex medical commission filed the affidavit in response to a writ petition filed by the National M.Sc Medical Teachers' Association (NMMTA) and other associations and individuals on the guidelines published in the Minimum Requirements for Annual MBBS admissions Regulations, 2020.

For more details, check out the link given below:

NMC reverses its stand on TEQ norms for non medical teachers, says old rules will be followed


Jenburkt pharma launches FDC- Nervijen D3

Known for its popular brand Nervijen, Mumbai-based Jenburkt Pharmaceuticals Limited has recently launched a fixed-dose combination (FDC) of Methylcobalmin & Vitamin-D3 (Cholecalciferol) under the brand name Nervijen D3 tablets in India.

This FDC aims to address the issue of Vitamin D3 and B12 deficiencies, concurrently seen in neuropathy patients due to nutritional deficiency.

The combination of Nervijen D3 consists of Methylcobalamin 1500mcg, Vitamin D3 1000 IU, Alpha Lipoic Acid 100mg, Folic acid 1.5mg, Benfotiamine 7.5mg, Inositol 1.5mg and Biotin 5mcg.

For more details, check out the link given below:

Jenburkt pharma launches FDC- Nervijen D3


SII QHPV vaccine against cervical cancer to be launched by year-end, to be priced between Rs 200-400: Adar Poonawalla

India's first indigenously developed quadrivalent Human Papilloma Virus (HPV) vaccine for the prevention of cervical cancer will be launched in a few months and made available to the people in an range of Rs 200-400, Serum Institute of India CEO Adar Poonawalla said on Thursday.

Speaking at an event held to announce the scientific completion of the vaccine, Union Minister of Science and Technology Jitendra Singh said the vaccine will be affordable and the government will ensure that it is accessible to the common man.

For more details, check out the link given below:

SII QHPV vaccine against cervical cancer to be launched by year-end, to be priced between Rs 200-400: Adar Poonawalla

Full View
Tags:    

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News